Director, Federal Government Affairs; Democratic Lead

Role Summary

The Director, Federal Government Affairs (Democratic Lead) will drive Bridge Bio’s federal policy strategy, shaping engagement across Congress, federal agencies, and key industry coalitions. They will serve as a principal representative and strategic lead for Bridge Bio’s federal policy priorities, ensuring the company’s voice informs national debates on drug development, biomedical innovation, and patient access to life‑changing therapies. As a core member of Bridge Bio’s Policy & Advocacy team, they will collaborate across scientific, regulatory, commercial, patient advocacy, and communications units to anticipate policy risks and shape opportunities that impact Bridge Bio’s pipeline and patient communities.

The Director will build and sustain trusted relationships with lawmakers, committee staff, and aligned stakeholders, ensuring Bridge Bio is positioned as a credible, influential stakeholder. This hybrid role is based in Washington, D.C.

• Federal Government Affairs Strategy:
  Demonstrated ability to develop and execute sophisticated federal engagement strategies that advance organizational priorities across Congress, federal agencies, and key policy making bodies. Brings a strong understanding of legislative and regulatory processes and can effectively shape, influence, and respond to evolving policy landscapes. Given Bridge Bio’s current landscape and existing team composition, this role will complement and expand the company’s reach by bringing deep experience within Democratic circles.
• Relationship‑Building & Stakeholder Engagement: A proven relationship‑builder with established networks in Congress and committee offices. Skilled at forging trusted partnerships with policymakers, industry groups, coalitions, and aligned advocacy organizations. Able to represent Bridge Bio with credibility, diplomacy, and compelling presence.
• Policy Analysis, Forecasting & Translation:
  Exceptional ability to monitor, interpret, and anticipate federal legislative and administrative actions affecting drug development, regulatory pathways, innovation incentives, and patient access. Adept at distilling complex policy issues into actionable insights for scientific, regulatory, commercial, and executive audiences.
• Cross‑Functional Collaboration & Influence:
  Thrives in a fast‑paced, matrixed environment. Works fluidly across functions—including Regulatory Affairs, Patient Advocacy, Corporate Communications, Commercial, and R&D—to embed policy considerations into pipeline planning and business strategy. Influences without authority and aligns stakeholders around shared objectives.
• Strategic Communication & Executive Support:
  Strong communicator who can craft clear, compelling briefing materials, talking points, and strategic recommendations for senior leaders. Able to serve as a trusted advisor on federal policy matters, supporting leadership visibility, external engagements, and internal decision‑making.
• Mission Orientation & Patient‑Centered Advocacy:
  Deep commitment to Bridge Bio’s mission and a demonstrated ability to translate patient‑centered values into effective public policy strategy. The Director will ensure that federal policy decisions support timely development and access to transformative therapies for patients with genetic diseases.

• A minimum of 10 years of relevant experience in federal government affairs, congressional work, biopharma policy advocacy, or life‑sciences government relations
• A bachelor’s degree is required, advanced degree in public policy, law, political science, or a related field preferred
• Strong preference for candidates who have operated at the senior‑most levels of Democratic House offices (e.g., Chief of Staff, Legislative Director, senior committee counsel/advisor), demonstrating trusted relationships and deep understanding of congressional decision‑making dynamics
• Established relationships within the U.S. Congress, federal agencies, and the White House, with a demonstrated track record of successful engagement and influence
• Strong knowledge of health policy, drug development processes, regulatory frameworks, and issues central to the…